title: Ceftriaxone-associated cholelithiasis: 30 min drip infusion versus bolus injection.
authors.forename: Ener Cagri
authors.initials: EC
authors.lastname: Dinleyici
authors.forename: Ozcan
authors.initials: O
authors.lastname: Bor
authors.forename: Mahmut
authors.initials: M
authors.lastname: Kebapci
authors.forename: Sultan D
authors.initials: SD
authors.lastname: Aydogdu
mesh_terms: D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects*; D002443:Ceftriaxone / Q000008:administration & dosage / Q000009:adverse effects*; D002648:Child; D002675:Child, Preschool; D002769:Cholelithiasis / Q000139:chemically induced* / Q000517:prevention & control; D017714:Community-Acquired Infections / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007223:Infant; D007262:Infusions, Intravenous; D007275:Injections, Intravenous; D008297:Male; D016920:Meningitis, Bacterial / Q000188:drug therapy*; D018410:Pneumonia, Bacterial / Q000188:drug therapy*; D014552:Urinary Tract Infections / Q000188:drug therapy*
chemical_list: D000900:Anti-Bacterial Agents; D002443:Ceftriaxone